ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,214.08
0.51%
Dow Jones
39,387.76
0.85%
US Dollar vs MXN
16.80156
0.04%
Brent Oil
84.075
0.15%
Bitcoin
62,856.53
-0.30%
Registration Strip Icon for discussion Regístrate para interactuar en nuestros foros activos para discutir con inversores de ideas afines.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Nexalin Technologies Inc (NXL)

  7. Nexalin Technologies Inc (NXL) Noticias

NXL

Nexalin Technologies (NXL)

Nexalin Technologies Inc
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:NXL
FechaHoraFuenteTítuloSímboloCompañía
09/05/202407:30GlobeNewswire Inc.Join Nexalin Technology’s Exclusive Live Investor Webinar and Q&A Session on May 23NASDAQ:NXLNexalin Technologies Inc
25/04/202409:44GlobeNewswire Inc.Nexalin Technology Regains Compliance with Nasdaq Continued Listing RequirementsNASDAQ:NXLNexalin Technologies Inc
09/04/202407:30GlobeNewswire Inc.Nexalin Technology Accelerates Manufacturing of its HALO™ Clarity Following Successful Usability, Feasibility, and Electrical TestingNASDAQ:NXLNexalin Technologies Inc
04/04/202412:00GlobeNewswire Inc.Nexalin Technology Awarded Key Patent Related to its Gen-3 HALO Clarity™, a Non-Invasive, Frequency-Based Deep-Brain Stimulation DeviceNASDAQ:NXLNexalin Technologies Inc
02/04/202407:30GlobeNewswire Inc.Nexalin Technology Announces the Appointment of Government Affairs Veteran William A. Hudson, Jr. to Military & Government Advisory BoardNASDAQ:NXLNexalin Technologies Inc
28/03/202407:30GlobeNewswire Inc.Nexalin Technology Announces Positive Results of Clinical Study Validating its Gen-2 tACS Device for Reducing Pain Among Veterans with Mild Traumatic Brain Injury at University of California, San DiegoNASDAQ:NXLNexalin Technologies Inc
14/03/202407:30GlobeNewswire Inc.Nexalin Technology Commences Sales of Gen-2 Neurostimulation Device to New Mental Health Center in Oman Dedicated to Nexalin’s TechnologyNASDAQ:NXLNexalin Technologies Inc
13/03/202407:30GlobeNewswire Inc.Nexalin Technology Announces Poster Presentation at “State of the Technology Meeting: Neurotrauma Diagnosis, Monitoring, and Assessment”NASDAQ:NXLNexalin Technologies Inc
08/02/202407:30GlobeNewswire Inc.Nexalin Technology Announces Regulatory Approval in Oman for Gen-2 Neurostimulation DeviceNASDAQ:NXLNexalin Technologies Inc
23/01/202407:30GlobeNewswire Inc.Nexalin Technology Awarded Key Patent Related to its Non-Invasive, Frequency-Based Deep-Brain Stimulation Device – the Transcranial Alternating Current Dynamic Frequency Stimulation (TACS) SystemNASDAQ:NXLNexalin Technologies Inc
11/01/202407:30GlobeNewswire Inc.Nexalin Technology Unveils Next-Generation HALO™ ClarityNASDAQ:NXLNexalin Technologies Inc
18/12/202307:30GlobeNewswire Inc.Nexalin Technology Reports Significant Positive Results of Clinical Study Supporting the Therapeutic Benefits of its Gen-2, 15 Milliamp Neurostimulation Device on Treatment-Resistant DepressionNASDAQ:NXLNexalin Technologies Inc
13/11/202315:38Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:NXLNexalin Technologies Inc
13/11/202313:38Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:NXLNexalin Technologies Inc
25/10/202307:30GlobeNewswire Inc.Nexalin Technology Announces Formation of New Military & Government Advisory Board to be Led by Government Affairs Veteran David LasseterNASDAQ:NXLNexalin Technologies Inc
16/10/202307:30GlobeNewswire Inc.Nexalin Technology Announces Publication of Groundbreaking Deep-Brain Stimulation Study in Leading Peer-Reviewed Journal; Validates the Ability of Nexalin’s Neurostimulation Device to Penetrate Deep Brain StructuresNASDAQ:NXLNexalin Technologies Inc
05/10/202311:09Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:NXLNexalin Technologies Inc
07/08/202307:30GlobeNewswire Inc.Nexalin Technology Reports Results of Clinical Study Supporting the Therapeutic Benefits of its Gen-2, 15 Milliamp Neurostimulation Device in Treating Migraine Headaches and Related SymptomsNASDAQ:NXLNexalin Technologies Inc
03/08/202307:30GlobeNewswire Inc.Nexalin’s CEO Mark White to be Interviewed Live on “The Big Biz Show” Today at 3PM Eastern TimeNASDAQ:NXLNexalin Technologies Inc
26/07/202307:30GlobeNewswire Inc.Nexalin Technology Announces New Public Sector Division to Capitalize on Opportunities to Serve U.S. Government AgenciesNASDAQ:NXLNexalin Technologies Inc
10/07/202307:30GlobeNewswire Inc.Nexalin Technology Announces Abstract Accepted for Presentation at 2023 Military Health System Research Symposium Validating the Potential of its Non-Invasive, Frequency-Based Deep-Brain Stimulation Device for the Treatment of Mild Traumatic Brain InjuryNASDAQ:NXLNexalin Technologies Inc
30/06/202314:15Edgar (US Regulatory)Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]NASDAQ:NXLNexalin Technologies Inc
30/06/202314:11Edgar (US Regulatory)Form 3/A - Initial statement of beneficial ownership of securities: [Amend]NASDAQ:NXLNexalin Technologies Inc
01/06/202307:30GlobeNewswire Inc.Nexalin Technology, Inc. and Wider Come Limited Announce Joint Venture Agreement to Advance Commercialization of Nexalin’s tACS Devices in the Asia Pacific RegionNASDAQ:NXLNexalin Technologies Inc
16/05/202312:22Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:NXLNexalin Technologies Inc
10/05/202316:19Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:NXLNexalin Technologies Inc
27/03/202306:00GlobeNewswire Inc.Nexalin Technology Provides 2022 Year-End Business UpdateNASDAQ:NXLNexalin Technologies Inc
24/01/202307:30GlobeNewswire Inc.Nexalin Technology Appoints Medical Device Veteran Michael Nketiah as Senior Vice President of Quality, Clinical and RegulatoryNASDAQ:NXLNexalin Technologies Inc
05/01/202307:30GlobeNewswire Inc.Nexalin Technology CEO Provides Letter to ShareholdersNASDAQ:NXLNexalin Technologies Inc
14/11/202213:00GlobeNewswire Inc.Nexalin Technology Announces Publication of a White Paper Validating its tACS Device for the Treatment of Generalized Anxiety DisorderNASDAQ:NXLNexalin Technologies Inc
 Showing the most relevant articles for your search:NASDAQ:NXL

Su Consulta Reciente

NYSE
NKE
Nike
NASDAQ
GOOGL
Alphabet
USOTC
BNPQY
BNP Paribas (QX)
NASDAQ
TSLA
Tesla
AMEX
XLE
Energy Select Sector SPDR
USOTC
ADDYY
Adidas (QX)
CCOM
US30
US 30
NYSE
CVX
Chevron
NYSE
DIS
Walt Disney
USOTC
DTEGY
Deutsche Telekom (QX)
NYSE
JPM
JP Morgan Chase
NASDAQ
MSFT
Microsoft
USOTC
BASFY
BASF (QX)
NASDAQ
QQQ
Invesco QQQ Trust Series 1
NYSE
AXP
American Express
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados